Business Description
Vineet Laboratories Ltd
ISIN : INE505Y01010
Share Class Description:
NSE:VINEETLAB: Ordinary SharesTotal Employee Number:
57Compare
Compare
Traded in other countries / regions
543298.India IPO Date
2021-06-15Description
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.99 | |||||
Debt-to-EBITDA | 5.28 | |||||
Interest Coverage | 1.24 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.5 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -45.7 | |||||
3-Year EBITDA Growth Rate | -11.4 | |||||
3-Year EPS without NRI Growth Rate | -4.4 | |||||
3-Year FCF Growth Rate | 24.1 | |||||
3-Year Book Growth Rate | -8.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 16.17 | |||||
9-Day RSI | 30.23 | |||||
14-Day RSI | 38.77 | |||||
3-1 Month Momentum % | 7.22 | |||||
6-1 Month Momentum % | 19.15 | |||||
12-1 Month Momentum % | 22.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 521.96 | |||||
Days Sales Outstanding | 57.2 | |||||
Days Payable | 278.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.5 | |||||
Shareholder Yield % | -43.53 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35 | |||||
Operating Margin % | 10.21 | |||||
Net Margin % | 1.87 | |||||
EBITDA Margin % | 14.45 | |||||
FCF Margin % | -22.25 | |||||
OCF Margin % | -20.26 | |||||
ROE % | 5.03 | |||||
ROA % | 1.11 | |||||
ROIC % | 7.58 | |||||
3-Year ROIIC % | 37.79 | |||||
ROC (Joel Greenblatt) % | 10.36 | |||||
ROCE % | 20.42 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.51 | |||||
PE Ratio without NRI | 39.51 | |||||
PS Ratio | 0.71 | |||||
PB Ratio | 1.54 | |||||
Price-to-Tangible-Book | 1.53 | |||||
EV-to-EBIT | 16.04 | |||||
EV-to-EBITDA | 11.54 | |||||
EV-to-Revenue | 1.67 | |||||
EV-to-FCF | -7.66 | |||||
Price-to-GF-Value | 3.55 | |||||
Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 3.56 | |||||
Earnings Yield (Greenblatt) % | 6.22 | |||||
FCF Yield % | -18.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vineet Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 594.01 | ||
| EPS (TTM) (₹) | 0.921 | ||
| Beta | 1.6303 | ||
| 3-Year Sharpe Ratio | 0.02 | ||
| 3-Year Sortino Ratio | 0.03 | ||
| Volatility % | 48.63 | ||
| 14-Day RSI | 38.77 | ||
| 14-Day ATR (₹) | 2.005304 | ||
| 20-Day SMA (₹) | 37.6985 | ||
| 12-1 Month Momentum % | 22.09 | ||
| 52-Week Range (₹) | 27.96 - 43.5 | ||
| Shares Outstanding (Mil) | 19.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vineet Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vineet Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vineet Laboratories Ltd Frequently Asked Questions
What is Vineet Laboratories Ltd(NSE:VINEETLAB)'s stock price today?
The current price of NSE:VINEETLAB is ₹35.79. The 52 week high of NSE:VINEETLAB is ₹43.50 and 52 week low is ₹27.96.
When is next earnings date of Vineet Laboratories Ltd(NSE:VINEETLAB)?
The next earnings date of Vineet Laboratories Ltd(NSE:VINEETLAB) is .
Does Vineet Laboratories Ltd(NSE:VINEETLAB) pay dividends? If so, how much?
Vineet Laboratories Ltd(NSE:VINEETLAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers